Further investigation of these genes, other known cancer-predisposing genes, and genes associated with DNA repair will aid in the disease management of families with hereditary diffuse gastric cancer without CDH1 pathogenic variants, whose risk of disease development is currently unknown. This evidence concerns the gene CDH1 and cancer.